Incidence of oxaliplatin hypersensitivity reaction among colorectal cancer patients: A 5-year retrospective study

BACKGROUND: Oxaliplatin is a third-generation platinum compound that has efficacy against colorectal cancer. Hypersensitivity reactions during oxaliplatin infusion are a key problem during its use, with the varying incidences and deficiencies of clearly identified risk factors. OBJECTIVE: To determi...

Descripción completa

Detalles Bibliográficos
Autores principales: Palapinyo, Sirinoot, Klaewsongkram, Jettanong, Sriuranpong, Virote, Areepium, Nutthada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Investigaciones y Publicaciones Farmaceuticas 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296088/
https://www.ncbi.nlm.nih.gov/pubmed/35919789
http://dx.doi.org/10.18549/PharmPract.2022.2.2635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296088/
https://www.ncbi.nlm.nih.gov/pubmed/35919789
http://dx.doi.org/10.18549/PharmPract.2022.2.2635

Ejemplares similares